Objective Many outcomes have been proposed in the assessment of psoriatic arthritis (PsA).
The Outcome Measures in Rheumatology (OMERACT) core set for PsA evaluation …

Abstract Introduction Psoriatic arthritis (PsA) is a multidimensional inflammatory disease for
which multiple outcome measures can be used to assess disease activity. In 2006, the …

Objective A meeting was convened by the Group for Research and Assessment of Psoriasis
and Psoriatic Arthritis (GRAPPA) and Outcome Measures in Rheumatology (OMERACT) to …

Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis
(PsA) clinical trials that represent both patients' and physicians' priorities. Methods We …

Selection of appropriate outcome measures in clinical trials and observational studies is key
to improving the understanding of PsA and effective management. In many cases, specific …

Introduction The objective was to develop a questionnaire that can be used to calculate a
score reflecting the impact of psoriatic arthritis (PsA) from the patients' perspective: the PsA …

In order to measure disease activity, progression, and change with therapy in psoriatic
arthritis (PsA), it is important to use accurate, reliable, and feasible outcome measures that …

Recent studies with biological therapy in psoriatic arthritis (PsA) have highlighted the need
for validated and widely accepted assessment tools and outcome measures for this disease …

Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical
phenotype. There has been considerable international collaboration over recent years to …

Objectives The Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire is a recently
developed patient-reported outcome measure (PROM) of disease impact in psoriatic arthritis …